HZNP logo

Horizon Therapeutics Public Limited (HZNP) Depreciation And Amortization

Annual D&A

$390.39 M
+$36.64 M+10.36%

31 December 2022

3-Year Change

+10.36%
HZNP annual depreciation & amortization is up +10.36% over the past 3 years

All-time High

$390.39 M
HZNP annual depreciation & amortization is currently at an all-time high
Annual Total Expenses$2.90 B
HZNP annual total expenses is $2.90 billion
Annual Operating Expenses$1.98 B
HZNP annual total operating expenses is $1.98 billion
Annual Revenue$3.63 B
HZNP annual revenue is $3.63 billion
Annual Net Income$521.48 M
HZNP annual net profit is $521.48 million

HZNP Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$96.28 M
+$1.43 M+1.50%

30 June 2023

3-Year Change

-0.26%
HZNP quarterly depreciation & amortization is down -0.26% over the past 3 years

All-time High

$99.08 M
HZNP quarterly depreciation & amortization is currently -2.82% below its historical high of $99.08 million
Quarterly Total Expenses$804.12 M
HZNP quarterly total expenses is $804.12 million
Quarterly Operating Expenses$584.16 M
HZNP quarterly total operating expenses is $584.16 million
Quarterly Revenue$944.96 M
HZNP quarterly revenue is $944.96 million
Quarterly Net Income$127.07 M
HZNP quarterly net profit is $127.07 million

HZNP Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$389.00 M
-$1.14 M-0.29%

30 June 2023

3-Year Change

+9.96%
HZNP TTM depreciation & amortization is up +9.96% over the past 3 years

All-time High

$390.39 M
HZNP TTM depreciation & amortization is currently -0.36% below its historical high of $390.39 million
Annual Total Expenses$2.90 B
HZNP annual total expenses is $2.90 billion
Annual Operating Expenses$1.98 B
HZNP annual total operating expenses is $1.98 billion
TTM Revenue$3.64 B
HZNP TTM revenue is $3.64 billion
TTM Net Income$438.00 M
HZNP TTM net profit is $438.00 million

HZNP TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HZNP Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+10.4%-0.3%+10.0%
5 y5 years+64.6%+61.0%+64.0%

HZNP Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-2.8%-0.4%

Horizon Therapeutics Public Limited Depreciation And Amortization History

DateAnnualQuarterlyTTM
June 2023
-
$96.28 M(+1.5%)
$389.00 M(-0.3%)
Mar 2023
-
$94.86 M(-4.0%)
$390.14 M(-0.1%)
Dec 2022
$390.39 M(+10.4%)
$98.77 M(-0.3%)
$390.39 M(+0.6%)
Sept 2022
-
$99.08 M(+1.7%)
$388.15 M(+1.2%)
June 2022
-
$97.43 M(+2.4%)
$383.55 M(+1.5%)
Mar 2022
-
$95.11 M(-1.5%)
$378.04 M(+6.9%)
Dec 2021
$353.75 M(+26.6%)
$96.53 M(+2.2%)
$353.75 M(+8.3%)
Sept 2021
-
$94.48 M(+2.8%)
$326.76 M(+7.9%)
June 2021
-
$91.92 M(+29.8%)
$302.79 M(+6.4%)
Mar 2021
-
$70.82 M(+1.8%)
$284.53 M(+1.8%)
Dec 2020
$279.45 M(+17.8%)
$69.55 M(-1.4%)
$279.45 M(+3.6%)
Sept 2020
-
$70.51 M(-4.3%)
$269.73 M(+4.3%)
June 2020
-
$73.66 M(+12.0%)
$258.54 M(+6.0%)
Mar 2020
-
$65.74 M(+9.9%)
$244.01 M(+2.9%)
Dec 2019
$237.16 M(-5.0%)
$59.82 M(+0.8%)
$237.16 M(-1.2%)
Sept 2019
-
$59.32 M(+0.3%)
$239.96 M(-1.4%)
June 2019
-
$59.13 M(+0.4%)
$243.31 M(-1.2%)
Mar 2019
-
$58.89 M(-6.0%)
$246.22 M(-1.4%)
Dec 2018
$249.76 M(-2.5%)
$62.62 M(-0.1%)
$249.76 M(+8.6%)
Sept 2018
-
$62.67 M(+1.0%)
$230.07 M(-3.1%)
June 2018
-
$62.03 M(-0.6%)
$237.54 M(-3.8%)
Mar 2018
-
$62.44 M(+45.4%)
$247.04 M(-3.5%)
Dec 2017
$256.09 M(+15.5%)
$42.93 M(-38.8%)
$256.09 M(-8.7%)
Sept 2017
-
$70.14 M(-1.9%)
$280.36 M(+6.9%)
June 2017
-
$71.53 M(+0.1%)
$262.15 M(+8.1%)
Mar 2017
-
$71.48 M(+6.4%)
$242.51 M(+9.4%)
Dec 2016
$221.66 M
$67.20 M(+29.4%)
$221.66 M(+11.5%)
Sept 2016
-
$51.94 M(+0.1%)
$198.78 M(+4.6%)
June 2016
-
$51.88 M(+2.5%)
$190.13 M(+11.4%)
DateAnnualQuarterlyTTM
Mar 2016
-
$50.64 M(+14.3%)
$170.65 M(+23.4%)
Dec 2015
$138.34 M(+306.8%)
$44.32 M(+2.4%)
$138.34 M(+25.3%)
Sept 2015
-
$43.28 M(+33.6%)
$110.37 M(+49.3%)
June 2015
-
$32.41 M(+76.8%)
$73.92 M(+57.5%)
Mar 2015
-
$18.34 M(+12.2%)
$46.94 M(+38.0%)
Dec 2014
$34.01 M(+265.3%)
$16.35 M(+139.5%)
$34.01 M(+60.9%)
Sept 2014
-
$6.83 M(+25.6%)
$21.13 M(+29.7%)
June 2014
-
$5.43 M(+0.6%)
$16.29 M(+27.4%)
Mar 2014
-
$5.40 M(+55.6%)
$12.79 M(+37.4%)
Dec 2013
$9.31 M(+68.1%)
$3.47 M(+75.1%)
$9.31 M(+20.5%)
Sept 2013
-
$1.98 M(+2.6%)
$7.73 M(+6.5%)
June 2013
-
$1.93 M(+0.6%)
$7.25 M(+13.6%)
Mar 2013
-
$1.92 M(+1.7%)
$6.38 M(+15.3%)
Dec 2012
$5.54 M(+31.9%)
$1.89 M(+25.3%)
$5.54 M(+16.0%)
Sept 2012
-
$1.51 M(+41.7%)
$4.78 M(+11.2%)
June 2012
-
$1.06 M(-1.1%)
$4.30 M(+0.9%)
Mar 2012
-
$1.08 M(-4.6%)
$4.26 M(+1.4%)
Dec 2011
$4.20 M(+41.2%)
$1.13 M(+9.7%)
$4.20 M(+1.3%)
Sept 2011
-
$1.03 M(+0.1%)
$4.14 M(+11.5%)
June 2011
-
$1.03 M(+1.1%)
$3.72 M(-4.2%)
Mar 2011
-
$1.02 M(-5.4%)
$3.88 M(+30.4%)
Dec 2010
$2.97 M(+3761.0%)
$1.07 M(+79.3%)
$2.97 M(+121.5%)
Sept 2010
-
$599.00 K(-49.6%)
$1.34 M(+38.6%)
June 2010
-
$1.19 M(+971.2%)
$968.00 K(-1444.4%)
Mar 2010
-
$111.00 K(-119.9%)
-$72.00 K(-193.5%)
Dec 2009
$77.00 K(+120.0%)
-$557.00 K(-347.6%)
$77.00 K(-87.9%)
Sept 2009
-
$225.00 K(+51.0%)
$634.00 K(+55.0%)
June 2009
-
$149.00 K(-42.7%)
$409.00 K(+57.3%)
Mar 2009
-
$260.00 K
$260.00 K
Dec 2008
$35.00 K
-
-

FAQ

  • What is Horizon Therapeutics Public Limited annual depreciation & amortization?
  • What is the all time high annual D&A for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited TTM depreciation & amortization?
  • What is the all time high TTM D&A for Horizon Therapeutics Public Limited?

What is Horizon Therapeutics Public Limited annual depreciation & amortization?

The current annual D&A of HZNP is $390.39 M

What is the all time high annual D&A for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high annual depreciation & amortization is $390.39 M

What is Horizon Therapeutics Public Limited quarterly depreciation & amortization?

The current quarterly D&A of HZNP is $96.28 M

What is the all time high quarterly D&A for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high quarterly depreciation & amortization is $99.08 M

What is Horizon Therapeutics Public Limited TTM depreciation & amortization?

The current TTM D&A of HZNP is $389.00 M

What is the all time high TTM D&A for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high TTM depreciation & amortization is $390.39 M